Julia F. Slejko, PhD, is an associate professor at the University of Maryland Baltimore and Co-Director of the PAVE Center, where her research is focused on better understanding elements of value for patients, public and decision makers. Dr. Slejko is an active leader in ISPOR – the Professional Society for Health Economics and Outcomes Research, serving as co-lead of the Women in HEOR initiative, associate editor at Value in Health, and recent member of the Health Science Policy Council.
Dr. Slejko earned her BA in molecular, cellular, and developmental biology from the University of Colorado Boulder and her PhD with a focus on pharmacoeconomics from the University of Colorado School of Pharmacy Center for Pharmaceutical Outcomes Research. She completed postdoctoral training at the University of Washington School of Pharmacy. Prior to her doctoral training, she spent 7 years in drug discovery at Array BioPharma in Boulder, Colorado.
This seminar will present the methods and findings of a recent study that elicited health inequality aversion measures among the United States public: the willingness to forgo improvements in total population health to reduce inequality between better- and worse-off groups. Results from the study support more robust and routine integration of equity concerns into healthcare decisions for policy and health technology assessment in the US.
Date: August 13th, 2026
Time: 12:00 – 1:00 PM ET
Join the virtual seminar: https://tuftsmedicine.zoom.us/j/97879639796?pwd=MWB541hdBPMPZ1va2Fu0XWT3BQsumG.1
Passcode: 497316
